Genital herpes

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

Alfasigma pens €125M deal for injectable form of HSV treatment

Italian pharma Alfasigma penned a 125 million euro deal for the rights to an injectable form of an HSV encephalitis treatment.
James Waldron Jan 15, 2026 6:45am
image of two race cars neck and neck

GSK surrenders HSV vaccine hopes after phase 2 fail

Sep 11, 2024 4:21am